Loading...

Green Thumb Industries Inc.

GTBIFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.83
$-0.08(-1.32%)

Green Thumb Industries Inc. GTBIF Peers

See (GTBIF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
GTBIF$5.83-1.32%1.4B28.05$0.21N/A
MKGAF$130.20+0.39%56.5B17.08$7.61+1.91%
MKKGY$25.77+0.27%55.7B16.95$1.52+1.95%
TKPHF$27.72+3.82%43.6B60.26$0.46+4.80%
HLNCF$4.82-0.41%43.3B22.93$0.21+1.81%
IPSEY$30.79-1.47%40.7B24.83$1.24+0.83%
SDZNY$58.56+2.20%25.2B-2929.75-$0.02+1.15%
TEVJF$17.80+0.00%20.4B-15.48-$1.15N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
SGIOY$8.24-2.49%14B12.11$0.68+1.93%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

GTBIF vs MKGAF Comparison

GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GTBIF stands at 1.4B. In comparison, MKGAF has a market cap of 56.5B. Regarding current trading prices, GTBIF is priced at $5.83, while MKGAF trades at $130.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GTBIF currently has a P/E ratio of 28.05, whereas MKGAF's P/E ratio is 17.08. In terms of profitability, GTBIF's ROE is +0.03%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.

Stock Price Comparison

Loading...

Frequently Asked Questions

;